Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04478578Recruiting

Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia

Role: collaborator

NCT04781426Completed

PrEP Among MSM and TG in Myanmar

Role: collaborator

NCT03158857Withdrawn

Hepatitis C Treatment Study in Myanmar

Role: collaborator

NCT03578133Completed

Causes of Pneumonia in Yangon

Role: collaborator

NCT03847870Completed

Rickettsiae in Myanmar

Role: collaborator

NCT03269266Completed

Scrub Typhus RDT Study

Role: collaborator

All 6 trials loaded